A “Disclosure Defense” in Liability Law

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-03-02-2005
Volume 29
Issue 3

In this time of liability reform, pharma deserves the chance to align its economic interests with its ethical obligations to the patient.

Recent Videos
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Jens Schmidt, associate director MSAT at Lonza
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology